Saturday, March 12, 2022 5:43:54 PM
We also thank Dr. Mario Roederer, Vaccine Research Center, for the gift of polyclonal IgG purified from SHIV-infected RMs.
Barrack lol
https://www.flowjo.com/about/company/founders
Bethesda, Maryland
https://irp.nih.gov/pi/mario-roederer
Patents by Inventor Mario Roederer
https://patents.justia.com/inventor/mario-roederer
Neutralizing antibodies to HIV-1 and their use
Patent number: 10035845
Abstract: Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.
Type: Grant
Filed: July 27, 2017
Date of Patent: July 31, 2018
Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, University of Washington
Inventors: John Mascola, Richard Wyatt, Xueling Wu, Yuxing Li, Carl-Magnus Hogerkorp, Mario Roederer, Zhi-yong Yang, Gary Nabel, Peter Kwong, Tongqing Zhou, Mark Connors, William Schief
& gp41 18 more times including John R. Mascola
https://www.linkedin.com/in/mario-roederer-a957a946?challengeId=AQF9sBRUMNaHvgAAAX-ATem7mwS0vbMEh23mUrw-JYM247XVX4zumc_P6GgC29ha3vdF-8ga0nv0MsRbyPTjiieD_Cyh-OyFvA&submissionId=e7affecc-84c3-db16-dc44-c8907ec3923e
Others viewed
Thomas Liechti
Postdoctoral Research Fellow at the Vaccine Research Center, National Institutes of Health
Bethesda, Maryland, United States
Education
University of Zurich University of Zurich Graphic
University of Zurich
Doctor of Philosophy (Ph.D.)Microbiology and Immunology
2011 - 2017
Multicolor flow cytometry phenotyping of B cells in HIV-1 infection; Establishing multicolor flow cytometry panels with up to 16 markers, Multidimensional single cell analysis with dimensionality reduction (t-SNE) and cluster identification (SPADE, Citrus) algorithms, Working with human pathogens in Biosafety level 3 environment, Establishing Luminex assays to analyze antibody responses against different HIV-1 derived proteins/peptides and different IgG isotypes contributing to binding activity
University of Bern (Official)University of Bern (Official) Graphic
University of Bern (Official)
Master of Science (M.Sc.)Microbiology and Immunology
2009 - 2011
I studied the function of surface IgD on neutrophils and basophils on the impact on allergy during my master thesis at the Institute of Immunology of the University Hospital Inselspital Bern under the supervision of Prof. Dr. Clemens Dahinden. The techniques included isolation of basophils and neutrophils, multicolor flow cytometry, ELISA, immune cell stimulation assays and co-cultures.
Barrack lol
https://www.flowjo.com/about/company/founders
Bethesda, Maryland
https://irp.nih.gov/pi/mario-roederer
Patents by Inventor Mario Roederer
https://patents.justia.com/inventor/mario-roederer
Neutralizing antibodies to HIV-1 and their use
Patent number: 10035845
Abstract: Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.
Type: Grant
Filed: July 27, 2017
Date of Patent: July 31, 2018
Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, University of Washington
Inventors: John Mascola, Richard Wyatt, Xueling Wu, Yuxing Li, Carl-Magnus Hogerkorp, Mario Roederer, Zhi-yong Yang, Gary Nabel, Peter Kwong, Tongqing Zhou, Mark Connors, William Schief
& gp41 18 more times including John R. Mascola
https://www.linkedin.com/in/mario-roederer-a957a946?challengeId=AQF9sBRUMNaHvgAAAX-ATem7mwS0vbMEh23mUrw-JYM247XVX4zumc_P6GgC29ha3vdF-8ga0nv0MsRbyPTjiieD_Cyh-OyFvA&submissionId=e7affecc-84c3-db16-dc44-c8907ec3923e
Others viewed
Thomas Liechti
Postdoctoral Research Fellow at the Vaccine Research Center, National Institutes of Health
Bethesda, Maryland, United States
Education
University of Zurich University of Zurich Graphic
University of Zurich
Doctor of Philosophy (Ph.D.)Microbiology and Immunology
2011 - 2017
Multicolor flow cytometry phenotyping of B cells in HIV-1 infection; Establishing multicolor flow cytometry panels with up to 16 markers, Multidimensional single cell analysis with dimensionality reduction (t-SNE) and cluster identification (SPADE, Citrus) algorithms, Working with human pathogens in Biosafety level 3 environment, Establishing Luminex assays to analyze antibody responses against different HIV-1 derived proteins/peptides and different IgG isotypes contributing to binding activity
University of Bern (Official)University of Bern (Official) Graphic
University of Bern (Official)
Master of Science (M.Sc.)Microbiology and Immunology
2009 - 2011
I studied the function of surface IgD on neutrophils and basophils on the impact on allergy during my master thesis at the Institute of Immunology of the University Hospital Inselspital Bern under the supervision of Prof. Dr. Clemens Dahinden. The techniques included isolation of basophils and neutrophils, multicolor flow cytometry, ELISA, immune cell stimulation assays and co-cultures.
